Acute pancreatitis after renal transplantation.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to J T Fang.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Continuous arteriovenous hemodialysis (CAVHD) offers a modified therapeutic approach for the patient with acute renal failure. The system is modified fron the CAVH write out method by adding two pumps to control the flow rate of the dialysis solution and to reduce the nursing load. The blood flow through the dialyzer is dependent on the net blood pressure gradient. Peritoneal dialysis or bicarbonate dialysate is infused through the dialysate ports utilizing both diffuse and convective transport for an average blood flow rate of 0.9 L/hour. The two pumps control the dialysate inflow and outflow rates. Ten patients with complications and acute renal failure were treated with CAVHD for periods ranging from 10 to 154 hours. Average urea clearance was 9.39 mL/min. Average creatinine clearance was 9.12 mL/min, and in stable patients, the mean BUN was maintained at 60 mg/dL and the mean serum creatinine level was 4.6 mg/dL. The average ultrafiltration rate obtained was 100 mL/hr and was adjusted for the body fluid condition. most patients tolerated CAVHD without further hemodynamic instability and did not develop serious complications. In conclusion, CAVHD is a safe and technically simple procedure, which is particularly suitable for hemodynamically unstable patients requiring fluid removal.
We studied a total of 100 patients (46 men, 54 women) with renal failure requiring hemodialysis therapy by using double lumen catheter for temporary vascular access through the internal jugular vein. Fifteen patients had acute renal failure and 85 patients had end stage renal disease (including 27 cases of DM nephropathy). The mean length of time the catheter was in situ was 18.7 +/- 11.1 days (2-67 days); the mean frequency of the hemodialysis performed through this access was 7.8 +/- 4.6 (1-27). Recirculation rate was 7.19 +/- 2.68% (3.2-10.7%). The blood flow during hemodialysis was 180-200 ml/min. There was no catheter related mortality. The most common complication was catheter related septicemia (4%). Local infection of the catheter entry site occurred in 3 cases. Inadequate blood flow was detected in 3 cases. Two episodes of arrhythmia (atrial premature contractions, short runs of ventricular tachycardia) developed during the first hemodialysis procedure. Hematoma due to accidental puncture of the carotid artery was noted in one case. Neither pneumothorax nor hemothorax was detected. Our experiences revealed that the percutaneous internal jugular vein catheterization with a double lumen catheter is a safe and efficient temporary vascular access for hemodialysis.